Chime Biologics, a leading global CDMO that enables its partners' success in biologics, and Waterstone, a reliable partner ...

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...

Aurobindo Pharma subsidiary CuraTeQ Biologics has received a GMP certificate of compliance for its biosimilars manufacturing ...

The company has has end-to-end capabilities in producing a full range of products from bulk drug substance to fill-finish and ...

AstraZeneca on Tuesday revealed that it’s adding $2 billion more to its current outlay in the U.S., representing a total ...

CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has received a Good Manufacturing Practice (GMP) ...

As a leading CDMO for bioconjugates, Lonza has produced over 1,000 cGMP batches for more than 70 programs since 2006. Lonza offers customers a fully integrated solution, spanning design and lead ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Shallcross, Chief Executive Officer of Theriva Biologics. "With funding from the Spanish Government and a small capital raise, we are in a position to advance our proprietary suspension cell line ...

dedicated to the development and manufacturing of biologics following current good manufacturing practice (cGMP). Avid was ...

Recent health industry updates include AstraZeneca increasing its 2024 outlook, Cardinal Health's strategic investments, and ...